Search All UT System Experts

Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts)

Philip Raskin, G. Matfin, S. L. Schwartz, L. Chaykin, P. L. Chu, R. Braceras, A. Wynne

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts)'. Together they form a unique fingerprint.

Medicine & Life Sciences